UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF

JACC. Heart failure, 2021-01, Vol.9 (1), p.13-24

2021

Volltextzugriff (PDF)

Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trial

Diabetes, obesity & metabolism, 2020-11, Vol.22 (11), p.2077-2088

2020

Volltextzugriff (PDF)

GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis

Diabetes research and clinical practice, 2021-04, Vol.174, p.108737-108737, Article 108737

2021

Volltextzugriff (PDF)

Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

American journal of kidney diseases, 2020-01, Vol.75 (1), p.84-104

2020

Volltextzugriff (PDF)

Association of Prediabetes With CKD Progression and Adverse Cardiovascular Outcomes: An Analysis of the CRIC Study

The journal of clinical endocrinology and metabolism, 2020-04, Vol.105 (4), p.e1772-e1780

2020

Volltextzugriff (PDF)

Determinants and Outcomes Associated With Urinary Calcium Excretion in Chronic Kidney Disease

The journal of clinical endocrinology and metabolism, 2022-01, Vol.107 (1), p.e281-e292

2022

Volltextzugriff (PDF)

Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry

Orphanet journal of rare diseases, 2022-06, Vol.17 (1), p.1-238, Article 238

2022

Volltextzugriff (PDF)

Differential effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose–response meta-analysis involving 10 randomized clinical trials and 71 553 individuals

European journal of endocrinology, 2023-07, Vol.189 (1), p.S17-S25

2023

Volltextzugriff (PDF)

The Impact of Restrictive Versus Conservative Intraoperative Fluid Strategies upon the Renal Outcome in Colorectal Surgeries. A Randomized Controlled Trial

SVU - International Journal of Medical Sciences (Online), 2023-07, Vol.6 (2), p.169-180

2023

Volltextzugriff (PDF)

Obesity, Metabolic Abnormality, and Progression of CKD

American journal of kidney diseases, 2018-09, Vol.72 (3), p.400-410

2018

Volltextzugriff (PDF)

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

American journal of nephrology, 2017-12, Vol.46 (6), p.462-472

2017

Volltextzugriff (PDF)

Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression

American journal of kidney diseases, 2021-09, Vol.78 (3), p.350-360.e1

2021

Volltextzugriff (PDF)

Long-term renal outcomes of patients with non-proliferative lupus nephritis

The Korean journal of internal medicine, 2023-09, Vol.38 (5), p.769

2023

Volltextzugriff (PDF)

Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension

Kidney international, 2015-09, Vol.88 (3), p.622-632

2015

Volltextzugriff (PDF)

The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease

Clinica chimica acta, 2023-07, Vol.547, p.117448-117448, Article 117448

2023

Volltextzugriff (PDF)

Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality

American journal of kidney diseases, 2016-08, Vol.68 (2), p.219-228

2016

Volltextzugriff (PDF)

Renal pathological implications in type 2 diabetes mellitus patients with renal involvement

Journal of diabetes and its complications, 2017-01, Vol.31 (1), p.114-121

2017

Volltextzugriff (PDF)

Roles of mesangial C3 and C1q deposition in the clinical manifestations and prognosis of IgAN

International immunopharmacology, 2023-07, Vol.120, p.110354-110354, Article 110354

2023

Volltextzugriff (PDF)

Timing of diuretic administration effects on urine volume in hospitalized patients

Frontiers in physiology, 2024-01, Vol.14, p.1208324-1208324

2024

Volltextzugriff (PDF)

Comparative effectiveness of cardiovascular, renal and safety outcomes of second‐line antidiabetic drugs use in people with type 2 diabetes: A systematic review and network meta‐analysis of randomised controlled trials

Diabetic medicine, 2022-03, Vol.39 (3), p.e14780-n/a

2022

Volltextzugriff (PDF)

Sodium‐glucose co‐transporter‐2 inhibitors and risk of adverse renal outcomes among patients with type 2 diabetes: A network and cumulative meta‐analysis of randomized controlled trials

Diabetes, obesity & metabolism, 2017-08, Vol.19 (8), p.1106-1115

2017

Volltextzugriff (PDF)

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk

Cardiovascular diabetology, 2022-01, Vol.21 (1), p.12-12, Article 12

2022

Volltextzugriff (PDF)

Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis

Cardiovascular diabetology, 2021-01, Vol.20 (1), p.14-14, Article 14

2021

Volltextzugriff (PDF)

The Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in Diabetic Patients: A Systematic Review and Meta-Analysis

Cardiorenal medicine, 2020-01, Vol.10 (1), p.1-10

2020

Volltextzugriff (PDF)

Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus

International journal of cardiology, 2022-10, Vol.364, p.104-111

2022

Volltextzugriff (PDF)

1 – 25 von 42.370

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39.568)
Mit Volltextzugriff
(35.426)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(40.708)
Französisch
(295)
Japanisch
(277)
Deutsch
(230)
Russisch
(223)
Spanisch
(220)
Chinesisch
(157)
Polnisch
(97)
Italienisch
(95)
Portugiesisch
(41)
Ungarisch
(36)
Niederländisch
(34)
Rumänisch
(17)
Croatian
(15)
Dänisch
(13)
Koreanisch
(12)
Finnisch
(11)
Schwedisch
(11)
Ukrainisch
(11)
Türkisch
(8)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(38.152)
Science & Technology
(36.851)
Life Sciences & Biomedicine
(35.776)
Treatment Outcome
(29.307)
Male
(26.051)
Female
(25.063)
Middle Aged
(20.272)
Aged
(16.677)
Adult
(13.666)
Urology & Nephrology
(13.362)
Retrospective Studies
(9.889)
Risk Factors
(8.902)
Biological And Medical Sciences
(8.464)
Medical Sciences
(8.418)
Cardiovascular System & Cardiology
(6.766)
Renal Dialysis
(6.575)
Time Factors
(6.561)
Surgery
(6.084)
Patients
(5.954)
Kidney Failure, Chronic - Therapy
(5.569)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(38.624)
Journals@Ovid Full Text
(20.194)
EZB Electronic Journals Library
(19.864)
IngentaConnect Journals
(19.251)
IngentaConnect Journals
(11.356)
Access via ScienceDirect (Elsevier)
(7.403)
SpringerNature Journals
(7.342)
Publisher website
(6.810)
Wiley Blackwell Single Titles
(5.282)
Wiley Online Library Full Collection 2018
(4.482)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(4.090)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(2.848)
Access via SAGE
(2.511)
Oxford journals
(1.840)
Oxford Journals 2020 Medicine
(1.720)
Access via Taylor & Francis
(1.448)
Taylor & Francis
(1.228)
Taylor & Francis Journals Complete
(1.128)
Nature Journals Online
(750)
BMJ journals (British Medical Journal and others)
(656)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF

Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trial

GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis

Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

Association of Prediabetes With CKD Progression and Adverse Cardiovascular Outcomes: An Analysis of the CRIC Study

Determinants and Outcomes Associated With Urinary Calcium Excretion in Chronic Kidney Disease

Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry

Differential effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose–response meta-analysis involving 10 randomized clinical trials and 71 553 individuals

The Impact of Restrictive Versus Conservative Intraoperative Fluid Strategies upon the Renal Outcome in Colorectal Surgeries. A Randomized Controlled Trial

Obesity, Metabolic Abnormality, and Progression of CKD

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression

Long-term renal outcomes of patients with non-proliferative lupus nephritis

Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension

The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease

Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality

Renal pathological implications in type 2 diabetes mellitus patients with renal involvement

Roles of mesangial C3 and C1q deposition in the clinical manifestations and prognosis of IgAN

Timing of diuretic administration effects on urine volume in hospitalized patients

Comparative effectiveness of cardiovascular, renal and safety outcomes of second‐line antidiabetic drugs use in people with type 2 diabetes: A systematic review and network meta‐analysis of randomised controlled trials

Sodium‐glucose co‐transporter‐2 inhibitors and risk of adverse renal outcomes among patients with type 2 diabetes: A network and cumulative meta‐analysis of randomized controlled trials

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk

Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis

The Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in Diabetic Patients: A Systematic Review and Meta-Analysis

Differential cardiovascular and renal benefits of SGLT2 inhibitors and GLP1 receptor agonists in patients with type 2 diabetes mellitus

Suchergebnisse filtern